ANAB
AnaptysBio IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.63B
P/E Ratio
—
EPS
$-1.02
Beta
0.41
52W High
$72.36
52W Low
$11.40
50-Day MA
$55.50
200-Day MA
$34.95
Dividend Yield
—
Profit Margin
-11.50%
Forward P/E
—
PEG Ratio
0.00
About AnaptysBio Inc
AnaptysBio, Inc., a clinical-stage biotechnology company, is dedicated to developing therapeutic product candidates for inflammation and immuno-oncology indications. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $232.39M |
| Gross Profit (TTM) | $103.61M |
| EBITDA | $41.34M |
| Operating Margin | -135.50% |
| Return on Equity | -114.50% |
| Return on Assets | 6.78% |
| Revenue/Share (TTM) | $8.22 |
| Book Value | $0.44 |
| Price-to-Book | 123.83 |
| Price-to-Sales (TTM) | 7.03 |
| EV/Revenue | 5.62 |
| EV/EBITDA | 22.32 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -8.00% |
| Shares Outstanding | $29.10M |
| Float | $19.55M |
| % Insiders | 5.74% |
| % Institutions | 104.36% |
Historical Volatility
HV 10-Day
45.47%
HV 20-Day
44.05%
HV 30-Day
44.08%
HV 60-Day
70.25%
HV Rank
7.1%
Volatility is currently expanding
Analyst Ratings
Consensus ($87.09 target)
3
Strong Buy8
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026